Summer School In Cardiovascular Medicine: Clinical & Experimental Xi Edition
Evento RES · di Executive Congress Srl · Pisa · 20 lug 2026
Evento terminato
Questo evento si è concluso il 24 luglio 2026.
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Trova ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.
- Crediti ECM
- 28
- 1 all'ora
- Costo
- Gratis
- Durata
- 28 ore
- Inizio
- 20 lug 2026
- Dove
- Polo Didattico Monastero “Le Benedettine”
- Piazza S. Paolo a Ripa D’Arno, Pisa (PI)
In sintesi
Questo corso ECM di tipo RES è offerto da Executive Congress Srl e assegna 28 crediti ECM. L'obiettivo formativo è: 3 - Documentazione clinica. Percorsi clinico-assistenziali diagnostici e riabilitativi, profili di assistenza - profili di cura.
Summer School in Cardiovascular Medicine (XI edizione), corso RES residenziale a Pisa, 20-24 luglio 2026. Aggiornamento multidisciplinare su fisiologia cardiovascolare, sindromi ischemiche, cardiomiopatie, imaging avanzato, aritmie e ipertensione polmonare. Rivolto a medici specialisti. 28 ECM.
Scheda rapida
- Provider
- Executive Congress Srl22 corsi in calendario
- Tipologia
- ResidenzialeCorso di aggiornamento
- Crediti ECM
- 2828 ore
- Costo
- Gratis
- Per chi
Medico Chirurgo · 14 discipline
- Allergologia Ed Immunologia Clinica
- Medicina Dello Sport
- Geriatria
- Chirurgia Vascolare
- Malattie Dell'apparato Respiratorio
- Cardiochirurgia
- Chirurgia Toracica
- Cardiologia
- Medicina Interna
- Reumatologia
- Anestesia E Rianimazione
- Medicina Generale (Medici Di Famiglia)
- Ematologia
- Malattie Metaboliche E Diabetologia
- Dove
- Polo Didattico Monastero “Le Benedettine”Piazza S. Paolo a Ripa D’Arno, Pisa (PI)
- Quando
- dal 20 lug 2026 al 24 lug 2026
- Rilevanza
- Nazionale
- Verifica finale
- questionario
- Faculty
- 72 docenti · 1 responsabile scientifico
- Posti
- 50
- Sponsor
- Con il contributo non vincolante di BAYER SPA, DAIICHI-SANKYO ITALIA, PIAM FARMACEUTICI SPA, AMICUS THERAPEUTICS, BOSTON SCIENTIFIC S.P.A, MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.
- ID evento
- 486462edizione 1
Programma
Monday, July 20 2026
20 luglio 2026 · Polo Didattico Monastero Le Benedettine, Pisa
- 09:00 Participants' Registration
- 09:10 Introduction (Raffaele De Caterina)
- 09:15 The University of Pisa and its Internationalization Program (Filippo Giorgi)
- 09:30 I SESSION – Principles of Cardiovascular Physiology and Pathophysiology — Biventricular Function and Mechanics in Health and Disease (Fabio Recchia)
- 09:50 I SESSION – Principles of Cardiovascular Physiology and Pathophysiology — Large Artery Function and Remodeling in Cardiovascular Disease (Carlo Palombo)
- 10:10 I SESSION – Principles of Cardiovascular Physiology and Pathophysiology — The autonomic nervous system control of cardiovascular functions (Gianfranco Parati)
- 10:30 Discussion
- 11:00 Coffee Break
- 11:30 I SESSION – Principles of Cardiovascular Physiology and Pathophysiology — Exercise Responses in Health and Cardiovascular Disease (Claudio Passino)
- 11:50 I SESSION – Principles of Cardiovascular Physiology and Pathophysiology — Practical session: From murmurs to mechanics: the pathophysiological basis of cardiac auscultation (Raffaele De Caterina)
- 12:10 I SESSION – Principles of Cardiovascular Physiology and Pathophysiology — Practical session: From murmurs to mechanics: the pathophysiological basis of lung auscultation (Alessandro Celi)
- 12:30 Discussion
- 13:00 LUNCH BREAK
- 14:00 II SESSION – Myocardial ischemic syndromes: Pathophysiology and Endotypes — Endothelial dysfunction as the final common pathway of atherosclerotic vascular disease (Lorenzo Ghiadoni)
- 14:20 II SESSION – Myocardial ischemic syndromes: Pathophysiology and Endotypes — Acute and non-acute myocardial ischemic syndromes – The need for a new classification (William E. Boden)
- 14:40 II SESSION – Myocardial ischemic syndromes: Pathophysiology and Endotypes — Diagnosis and risk stratification of non-acute myocardial ischemic syndromes (Danilo Neglia)
- 15:00 Discussion
- 15:30 Break
- 15:50 II SESSION – Myocardial ischemic syndromes: Pathophysiology and Endotypes — Myocardial infarction with non-obstructive coronary arteries (Doralisa Morrone)
- 16:10 II SESSION – Myocardial ischemic syndromes: Pathophysiology and Endotypes — Acute and non-acute myocardial ischemic syndromes: the view of the interventional cardiologist (Giulio Stefanini)
- 16:30 II SESSION – Myocardial ischemic syndromes: Pathophysiology and Endotypes — Acute and non-acute myocardial ischemic syndromes: the view of the cardiac surgeon (Andrea Colli)
- 16:50 Discussion
- 17:30 End of the First Day's Activities
Tuesday, July 21 2026
21 luglio 2026 · Polo Didattico Monastero Le Benedettine, Pisa
- 09:30 III SESSION – Modifiable risk factors for cardiovascular health: redefining the trajectory of prevention — Arterial hypertension: from mechanisms to complications (Stefano Masi)
- 09:50 III SESSION – Modifiable risk factors for cardiovascular health: redefining the trajectory of prevention — Antihypertensive treatments: old and new drugs and devices (Stefano Taddei)
- 10:10 III SESSION – Modifiable risk factors for cardiovascular health: redefining the trajectory of prevention — The polypill: a 'Trojan Horse' for clinical inertia? (Claudio Borghi)
- 10:30 Discussion
- 11:00 Coffee Break
- 11:30 IV SESSION – DYSLIPIDEMIAS — Changes of paradigm in lipid lowering therapy with old and new drugs. Not only LDL: new CETP inhibitors, new triglyceride lowering agents (Alberto Corsini)
- 11:50 IV SESSION – DYSLIPIDEMIAS — The Lipid Revolution: Targeting Residual Risk beyond LDL? Focus on Lp(a) (Danilo Norata)
- 12:10 IV SESSION – DYSLIPIDEMIAS — Perhaps beyond lipids: Omega-3 fatty acids in patients with cardiac and renal disease (Marcello Arca)
- 12:30 Discussion
- 13:00 Lunch Break
- 14:00 V SESSION – Obesity and diabetes — Lifestyle interventions: the new frontier (Luigi Fontana)
- 14:20 V SESSION – Obesity and diabetes — GLP-1 agonists in patients with and without cardiovascular disease (Ferruccio Santini)
- 14:40 V SESSION – Obesity and diabetes — Combination of GLP1 agonists with other gastro-hormonal targets in patients with and without cardiovascular disease: dual GLP-1/GIP and triple GLP-1/GIP/glucagon receptor agonists (Giovanni Ceccarini)
- 15:10 V SESSION – Obesity and diabetes — SGLT2 Inhibitors: From glucose lowering to organ protection (Stefano Del Prato)
- 15:40 Discussion
- 16:30 End of the Second Day's Activities
Wednesday, July 22 2026
22 luglio 2026 · Polo Didattico Monastero Le Benedettine, Pisa
- 08:50 VI SESSION – Cardiomyopathies and heart failure — Hypertrophic cardiomyopathy: new therapeutic horizons (Maurizio Pieroni)
- 09:10 VI SESSION – Cardiomyopathies and heart failure — Cardiac amyloidosis: classification, clinical red flags and multidisciplinary approach (Giuseppe Vergaro)
- 09:30 VI SESSION – Cardiomyopathies and heart failure — Cardiac amyloidosis as a unique pathophysiological model for targeted and disease-modifying therapies: stabilizers, silencers, depleters and gene editing (Aldostefano Porcari)
- 09:50 VI SESSION – Cardiomyopathies and heart failure — Identifying Fabry Disease within the Landscape of Infiltrative Cardiomyopathies (Francesca Graziani)
- 10:10 VI SESSION – Cardiomyopathies and heart failure — Aortic stenosis and transcatheter aortic valve implantation (TAVI): state of the art (Carlo Di Mario)
- 10:30 Discussion — Discussant: Lorenzo Bazan
- 11:00 Coffee Break
- 11:30 VI SESSION – Cardiomyopathies and heart failure (cont.) — Steroidal and non-steroidal mineralocorticoid receptor antagonists (Enrico Agabiti Rosei)
- 11:50 VI SESSION – Cardiomyopathies and heart failure (cont.) — Sodium guanylate cyclase stimulators: for many, for a few or for all? (Alberto Giannoni)
- 12:10 VI SESSION – Cardiomyopathies and heart failure (cont.) — The evolution of device therapy in heart failure (Giulio Zucchelli)
- 12:30 Discussion — Discussant: Lorenzo Bazan
- 13:30 End of Third Day's Activities
Thursday, July 23 2026
23 luglio 2026 · Polo Didattico Monastero Le Benedettine, Pisa
- 09:00 VII SESSION – Advanced cardiovascular imaging — Imaging of vascular disease (Gabriele Masini)
- 09:20 VII SESSION – Advanced cardiovascular imaging — Echocardiography and point-of-care ultrasound (Luna Gargani)
- 09:40 VII SESSION – Advanced cardiovascular imaging — Cardiac computed tomography (Gianluca Pontone)
- 10:00 VII SESSION – Advanced cardiovascular imaging — Nuclear cardiology (Gayane Aghakhanyan)
- 10:20 VII SESSION – Advanced cardiovascular imaging — Cardiac magnetic resonance imaging (Giovanni Donato Aquaro)
- 10:40 Discussion
- 11:00 Coffee Break
- 11:30 VIII SESSION – Valvular heart disease – From diagnosis to treatment — SGLT2 Inhibitors and GLP-1 agonists in heart failure with reduced and preserved ejection fraction (Giulia Costa)
- 11:50 VIII SESSION – Valvular heart disease – From diagnosis to treatment — Mitral transcatheter interventions: state of the art (Tullio Palmerini)
- 12:10 VIII SESSION – Valvular heart disease – From diagnosis to treatment — Tricuspid transcatheter interventions: state of the art (Marco De Carlo)
- 12:30 Discussion
- 13:00 Lunch Break
- 14:00 SESSION IX – Electrophysiology and Arrhythmias — From the ecg to the electrophysiology study: how to find heart rhythm abnormalities (Matteo Parollo)
- 14:20 SESSION IX – Electrophysiology and Arrhythmias — Sudden death and cardiomyopathies: How to identify patients at risk and when to treat ventricular tachycardias (Stefano Viani)
- 14:40 SESSION IX – Electrophysiology and Arrhythmias — The ECG: the cardiologist's best friend from grid paper to Artificial Intelligence (Raffaele De Lucia)
- 15:00 Discussion
- 15:30 Break
- 15:50 SESSION IX – Electrophysiology and Arrhythmias (cont.) — Atrial cardiomyopathy: cause or bystander for future stroke? (Lin Yee Chen)
- 16:10 SESSION IX – Electrophysiology and Arrhythmias (cont.) — Atrial fibrillation: from pathogenesis-guided anti-arrhythmic therapy to ablation (Luca Segreti)
- 16:30 SESSION IX – Electrophysiology and Arrhythmias (cont.) — Current and forthcoming antithrombotic approaches (Raffaele De Caterina) — Discussants: Sara Latrofa, Alice Russo
- 16:50 Discussion
- 17:30 End of the Fourth Day's Activities
Friday, July 24 2026
24 luglio 2026 · Polo Didattico Monastero Le Benedettine, Pisa
- 09:30 X SESSION – Pulmonary Circulation and Pulmonary Hypertension — Pulmonary arterial hypertension: Definitions, classifications, diagnosis, risk stratification and treatment (Rosalinda Madonna)
- 09:50 X SESSION – Pulmonary Circulation and Pulmonary Hypertension — Practical session: Right heart catheterization and provocative tests for pulmonary hypertension (Edoardo Airo)
- 10:10 X SESSION – Pulmonary Circulation and Pulmonary Hypertension — Focus on cardiopulmonary exercise test in the diagnosis of pulmonary hypertension (Marco Vicenzi)
- 10:30 Discussion
- 11:00 Coffee Break
- 11:30 X SESSION – Pulmonary Circulation and Pulmonary Hypertension (cont.) — Pulmonary arterial hypertension with rheumatologic diseases (Marco Di Battista)
- 11:50 X SESSION – Pulmonary Circulation and Pulmonary Hypertension (cont.) — Chronic thromboembolic pulmonary disease and hypertension (Sandeep Sahay)
- 12:10 X SESSION – Pulmonary Circulation and Pulmonary Hypertension (cont.) — Pulmonary hypertension secondary to lung disease (Roberta Pancani)
- 12:30 Discussion
- 13:30 Completion of the ECM Questionnaire
- 13:45 Discussion of the Results of the Assessment Tests
- 14:00 Conclusion of Activities
Dettagli della formazione
- Obiettivo formativo
- n. 3 · Documentazione clinica. Percorsi clinico-assistenziali diagnostici e riabilitativi, profili di assistenza - profili di curaObiettivi di processo
- Metodologie didattiche
- lezioni magistrali, serie di relazioni su tema preordinato
- Verifica della presenza
- Firma Di Presenza
- Verifica dell'apprendimento
- Questionario A Risposta Multipla
Responsabili e docenti
- RESPONSABILE SCIENTIFICO, MODERATORE, RELATORE
- Raffaele De Caterina
- MODERATORI
- Mattia AlbertiLorenzo BazanLaura CarrozziLorenzo FaggioniGino GrifoniSara LatrofaAndrea NataliAlice RussoGuido SalvettiFrancesco SbranaAlessandro Sticchi
- MODERATORI, RELATORI
- Marco De CarloLuna GarganiRosalinda MadonnaDoralisa MorroneCarlo PalomboLuca SegretiStefano TaddeiStefano VianiGiulio Zucchelli
- RELATORI
- Enrico Agabiti RoseiGayane AghakhanyanEdoardo AiroGiovanni Donato AquaroMarcello ArcaWilliam BodenClaudio BorghiGiovanni CeccariniAlessandro CeliLin Yee ChenAndrea ColliAlberto CorsiniGiulia CostaRaffaele De LuciaStefano del PratoMarco di BattistaCarlo di MarioLuigi FontanaLorenzo GhiadoniAlberto GiannoniFilippo GiorgiFrancesca GrazianiStefano MasiGabriele MasiniDanilo NegliaDanilo NorataTullio PalmeriniRoberta PancaniGianfranco ParatiMatteo ParolloClaudio PassinoMaurizio PieroniGianluca PontoneAldostefano PorcariFabio RecchiaSahay SandeepFerruccio SantiniMichele SenniGiulio StefaniniGiuseppe VergaroMarco Vicenzi
Razionale scientifico
Dal programma del provider.
The Summer and Winter Schools Initiative of the University of Pisa was launched in 2013 with the aim of fostering international exchange among students, postgraduate trainees, and early-career researchers, and of strengthening cooperation with foreign universities. The initiative is grounded in the conviction that the sharing of knowledge, academic perspectives, and research projects is a cornerstone of critical thinking and a driver toward a better and more inclusive world.
This call from the Academic Authorities, strongly supported by the International Division of the University of Pisa, was enthusiastically embraced by numerous Departments and Research Groups across a wide range of disciplines, from Mathematics and Physics to the Humanities and Health Sciences. Among the earliest initiatives activated in 2013 was the Cardiovascular Summer School, which has been held annually ever since, with the exception of a compulsory two-year interruption during the COVID-19 pandemic.
Over time, the School has evolved both in scope and denomination, reflecting the expanding range of topics addressed. Its titles have included "Updates in Cardiovascular Pathophysiology", "Cardiolung. Updates in Cardiovascular and Pulmonary Pathophysiology", and, for the current 2025 Edition, "Summer School in Cardiovascular Medicine. Clinical and Experimental". Participation has steadily increased, from an initial cohort of approximately 20 attendees to the current cap of 100 participants. The Summer School is designed as an intensive, typically one-week course, characterized by a strong translational and multidisciplinary approach. Its objective is to provide state-of-the-art and cutting-edge insights into major cardiovascular topics, spanning basic science, pathophysiology, and clinical practice. Particular emphasis is placed on fostering scientific reasoning and critical thinking through interactive sessions and direct dialogue between faculty members and participants.
Traditionally, the target audience has consisted primarily of undergraduate and early postgraduate students in Medicine and Life Sciences, PhD candidates, and trainees in the initial years of postgraduate medical programs. In the current edition, the course will also be open to practicing physicians—predominantly cardiologists—offering an in-depth exploration of rapidly evolving areas of cardiovascular research and innovation.
The Course provides a unique opportunity to engage, in a collegial and stimulating environment, with highly qualified local and international faculty from prestigious Italian and foreign institutions. Lectures and discussions address key clinical challenges as well as emerging scientific themes across the broad spectrum of cardiovascular medicine and pathophysiology.
The Pisa "Cardiovascular Summer School. Clinical and Experimental" is officially recognized with European Credit Transfer and Accumulation System (ECTS) credits (typically 3–4), as well as Italian academic credits. Younger participants are formally enrolled as temporary students of the University of Pisa for the duration of the course and benefit from all associated academic facilities and services.
Domande frequenti
- Quanti crediti ECM assegna?
- «Summer School In Cardiovascular Medicine» assegna 28 crediti ECM a fronte di 28 ore di formazione (1 crediti l'ora).
- Si svolge online o in presenza?
- In presenza: «Summer School In Cardiovascular Medicine» è un evento residenziale (RES), a Pisa (Toscana).
- Quando si svolge?
- «Summer School In Cardiovascular Medicine» si svolge dal 20 lug 2026 al 24 lug 2026 a Pisa (Toscana).
- A quali professioni sanitarie è accreditato?
- «Summer School In Cardiovascular Medicine» è accreditato per Medico Chirurgo, nelle discipline Allergologia Ed Immunologia Clinica, Medicina Dello Sport, Geriatria, Chirurgia Vascolare, Malattie Dell'apparato Respiratorio e altre 9. Solo chi rientra in queste professioni matura i crediti.
- Quanto costa?
- «Summer School In Cardiovascular Medicine» è gratuito: l'iscrizione non ha costi e i crediti valgono esattamente quanto quelli di un corso a pagamento.
- Chi eroga il corso?
- «Summer School In Cardiovascular Medicine» è erogato da Executive Congress Srl, provider ECM accreditato Agenas con id 661.
- Conviene rispetto a un corso FAD gratuito sullo stesso obiettivo?
- Dipende da cosa cerchi. Ci sono 5 alternative gratuite sullo stesso obiettivo per medico chirurgo (vedi tabella), tutte in presenza. Questo evento ha senso se ti interessa il tema o se sei vicino a Pisa: il costo è zero in entrambi i casi, cambia solo il tempo.
- Quanto pesa questo corso sull'obbligo del triennio 2026-2028?
- 28 crediti sono il 18,7% dei 150 crediti richiesti nel triennio. Con l'esonero o la riduzione per chi ha completato il triennio precedente la quota percentuale sale.
- Imposta la tua professione per il calcolo esatto →
- C'è un limite ai crediti RES che posso accumulare nel triennio?
- No: non esiste un tetto per i crediti da eventi residenziali. Il limite riguarda solo la formazione sponsorizzata (o l'autoformazione), non la tipologia dell'evento.
- A cosa serve un credito di area di processo?
- Gli obiettivi di processo sono meno frequenti nell'offerta ECM rispetto a quelli tecnico-professionali. Nel dossier formativo individuale ogni area vale almeno il 10% del piano: questo corso aiuta a coprire quella quota senza spendere.
- Posso sommare più corsi di Executive Congress Srl?
- Sì, non c'è limite per provider. Executive Congress Srl ha 22 corsi in calendario (99% gratuiti, in media 6,7 crediti l'uno).
Alternative sullo stesso obiettivo
- Meeting Interdisciplinare Di Neuroradiologia, Neurochirurgia E NeurologiaFondazione Ospedale Isola Tiberina – Gemelli Isola · FSC · entro il 12/10/202650 creditigratis
- Incontri Del Gruppo Multidisciplinare Dei Tumori Urologici. Tumour Board UrologicoFondazione Ospedale Isola Tiberina – Gemelli Isola · FSC · entro il 28/10/202650 creditigratis
- Incontri Del Gruppo Multidisciplinare Dei Tumori Dell’Esofago E Dello Stomaco. Tumor Board Esofago-StomacoFondazione Ospedale Isola Tiberina – Gemelli Isola · FSC · entro il 29/10/202650 creditigratis
- Discussione Multidisciplinare Casi Clinici ChmIstituto Europeo Di Oncologia · RES · entro il 09/10/202648 creditigratis
- Incontri Del Gruppo Multidisciplinare Dei Tumori Cutanei, Melanoma E Non-Melanoma Skin Cancer (Nmsc). Multidisciplinary Skin Tumor BoardFondazione Ospedale Isola Tiberina – Gemelli Isola · FSC · entro il 13/10/202626 creditigratis
ECM in numeri
Come si colloca questo corso
Confronto con il catalogo pubblico Agenas, aggiornato al 30/09/2026. Questo corso è gratuito.
- Medico Chirurgo: 22.964 edizioni a catalogo, 70,1% gratuite, credito mediano € 22,00
- Residenziale: 70,8% del catalogo, 67,8% gratuite, credito mediano € 23,81
- Si svolge in Toscana: 1.680 edizioni con sede nel territorio, 66,8% gratuite, credito mediano € 27,89.
- Obiettivo n. 3 (documentazione clinica e percorsi assistenziali): lo dichiara il 24,3% del catalogo, con il 75,1% di edizioni gratuite. Il corso è accreditato per 14 discipline; la mediana del catalogo è 7.
Radar delle professioniPrezzi ECMIl conto del triennioI 38 obiettivi formativi
Fonte dati per questo evento: Agenas. Evento organizzato da provider terzo. Trova ECM riporta dati pubblici dell'evento a scopo informativo e non è responsabile né del corso né dei contenuti, né ha accordi commerciali o di collaborazione con il provider.